Fate of hematopoietic stem cells determined by Notch1 signaling (Review)

Ge,Yidong; Wang,Jie; Zhang,Hui; Li,Jinyun; Ye,Meng; Jin,Xiaofeng

doi:10.3892/etm.2021.11093

Fate of hematopoietic stem cells determined by Notch1 signaling (Review)

Authors:
- Yidong Ge
- Jie Wang
- Hui Zhang
- Jinyun Li
- Meng Ye
- Xiaofeng Jin
View Affiliations

Affiliations: The Affiliated Hospital of Medical School, Ningbo University, Ningbo, Zhejiang 315020, P.R. China
Published online on: December 27, 2021 https://doi.org/10.3892/etm.2021.11093
Article Number: 170
Copyright: © Ge et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Regulation of the fate of hematopoietic stem cells (HSCs), including silencing, self‑renewal or differentiation into blood line cells, is crucial to maintain the homeostasis of the human blood system and prevent leukemia. Notch1, a key receptor in the Notch signaling pathway, plays an important regulatory role in these properties of HSCs, particularly in the maintenance of the stemness of HSCs. In recent decades, the ubiquitination modification of Notch1 has been gradually revealed, and also demonstrated to affect the proliferation and differentiation of HSCs. Therefore, a detailed elucidation of Notch1 and its ubiquitination modification may help to improve understanding of the maintenance of HSC properties and the pathogenesis of leukemia. In addition, it may aid in identifying potential therapeutic targets for specific leukemias and provide potential prognostic indicators for HSC transplantation (HSCT). In the present review, the association between Notch1 and HSCs and the link between the ubiquitination modification of Notch1 and HSCs were described. In addition, the association between abnormal HSCs mediated by Notch1 or ubiquitinated Notch1and T‑cell acute lymphoblastic leukemia (T‑ALL) was also examined, which provides a promising direction for clinical application.

View Figures

View References

1	Nawab K, Bhere D, Bommarito A, Mufti M and Naeem A: Stem cell therapies: A way to promising cures. Cureus. 11(e5712)2019.PubMed/NCBI View Article : Google Scholar
2	Zakrzewski W, Dobrzynski M, Szymonowicz M and Rybak Z: Stem cells: Past, present, and future. Stem Cell Res Ther. 10(68)2019.PubMed/NCBI View Article : Google Scholar
3	Wang D, Bu F and Zhang W: The role of Ubiquitination in regulating embryonic stem cell maintenance and cancer development. Int J Mol Sci. 20(2667)2019.PubMed/NCBI View Article : Google Scholar
4	Wang X: Stem cells in tissues, organoids, and cancers. Cell Mol Life Sci. 76:4043–4070. 2019.PubMed/NCBI View Article : Google Scholar
5	Aponte PM and Caicedo A: Stemness in cancer: Stem cells, cancer stem cells, and their microenvironment. Stem Cells Int. 2017(5619472)2017.PubMed/NCBI View Article : Google Scholar
6	Ruan Y, Kim HN, Ogana H and Kim YM: Wnt signaling in leukemia and its bone marrow microenvironment. Int J Mol Sci. 21(6247)2020.PubMed/NCBI View Article : Google Scholar
7	Roo JJD and Staal FJT: Cell signaling pathway reporters in adult hematopoietic stem cells. Cells. 9(2264)2020.PubMed/NCBI View Article : Google Scholar
8	Althoff MJ, Nayak RC, Hegde S, Wellendorf AM, Bohan B, Filippi MD, Xin M, Lu QR, Geiger H, Zheng Y, et al: Yap1-Scribble polarization is required for hematopoietic stem cell division and fate. Blood. 136:1824–1836. 2020.PubMed/NCBI View Article : Google Scholar
9	Pajcini KV, Speck NA and Pear WS: Notch signaling in mammalian hematopoietic stem cells. Leukemia. 25:1525–1532. 2011.PubMed/NCBI View Article : Google Scholar
10	Palomero T and Ferrando A: Oncogenic NOTCH1 control of MYC and PI3K: Challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas. Clin Cancer Res. 14:5314–5317. 2008.PubMed/NCBI View Article : Google Scholar
11	Pettersson S, Sczaniecka M, McLaren L, Russell F, Gladstone K, Hupp T and Wallace M: Non-degradative ubiquitination of the Notch1 receptor by the E3 ligase MDM2 activates the Notch signalling pathway. Biochem J. 450:523–536. 2013.PubMed/NCBI View Article : Google Scholar
12	Kar R, Jha SK, Ojha S, Sharma A, Dholpuria S, Raju VSR, Prasher P, Chellappan DK, Gupta G, Kumar Singh S, et al: The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues. Cancer Rep (Hoboken). 4(e1369)2021.PubMed/NCBI View Article : Google Scholar
13	Hori K, Sen A, Kirchhausen T and Artavanis-Tsakonas S: Synergy between the ESCRT-III complex and Deltex defines a ligand-independent Notch signal. J Cell Biol. 195:1005–1015. 2011.PubMed/NCBI View Article : Google Scholar
14	King B, Trimarchi T, Reavie L, Xu L, Mullenders J, Ntziachristos P, Aranda-Orgilles B, Perez-Garcia A, Shi J, Vakoc C, et al: The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell. 153:1552–1566. 2013.PubMed/NCBI View Article : Google Scholar
15	Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G, Ferrando A and Aifantis I: The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med. 204:1825–1835. 2007.PubMed/NCBI View Article : Google Scholar
16	Zhu W, Zhu Y, Xu H, Wang T, Wang J, Meng M, Liu Y, Yan H, Yang Q and Liu P: Flavone inhibited proliferation of T-ALL by promoting c-Cbl-induced ubiquitinylation and degradation of Notch1. Biochem Biophys Res Commun. 522:684–689. 2020.PubMed/NCBI View Article : Google Scholar
17	Zieba JT, Chen YT, Lee BH and Bae Y: Notch signaling in skeletal development, homeostasis and pathogenesis. Biomolecules. 10(332)2020.PubMed/NCBI View Article : Google Scholar
18	Chikara S and Reindl KM: Notch signaling: A hero or villain in the war against cancer? Transl Lung Cancer Res. 2:449–451. 2013.PubMed/NCBI View Article : Google Scholar
19	Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H and Dorken B: Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 99:3398–3403. 2002.PubMed/NCBI View Article : Google Scholar
20	Li L, Tang P, Li S, Qin X, Yang H, Wu C and Liu Y: Notch signaling pathway networks in cancer metastasis: A new target for cancer therapy. Med Oncol. 34(180)2017.PubMed/NCBI View Article : Google Scholar
21	Espinoza I, Pochampally R, Xing F, Watabe K and Miele L: Notch signaling: Targeting cancer stem cells and epithelial-to-mesenchymal transition. Onco Targets Ther. 6:1249–1259. 2013.PubMed/NCBI View Article : Google Scholar
22	Wu J and Bresnick EH: Bare rudiments of notch signaling: How receptor levels are regulated. Trends Biochem Sci. 32:477–485. 2007.PubMed/NCBI View Article : Google Scholar
23	Meloty-Kapella L, Shergill B, Kuon J, Botvinick E and Weinmaster G: Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin. Dev Cell. 22:1299–1312. 2012.PubMed/NCBI View Article : Google Scholar
24	Fischer A and Gessler M: Delta-Notch-and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res. 35:4583–4596. 2007.PubMed/NCBI View Article : Google Scholar
25	Bessho Y, Sakata R, Komatsu S, Shiota K, Yamada S and Kageyama R: Dynamic expression and essential functions of Hes7 in somite segmentation. Genes Dev. 15:2642–2647. 2001.PubMed/NCBI View Article : Google Scholar
26	Fischer A, Schumacher N, Maier M, Sendtner M and Gessler M: The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18:901–911. 2004.PubMed/NCBI View Article : Google Scholar
27	Dohda T, Maljukova A, Liu L, Heyman M, Grandér D, Brodin D, Sangfelt O and Lendahl U: Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. Exp Cell Res. 313:3141–3152. 2007.PubMed/NCBI View Article : Google Scholar
28	Ronchini C and Capobianco AJ: Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): Implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol. 21:5925–5934. 2001.PubMed/NCBI View Article : Google Scholar
29	Demarest RM, Dahmane N and Capobianco AJ: Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia. Blood. 117:2901–2909. 2011.PubMed/NCBI View Article : Google Scholar
30	Zhang P, Yang Y, Nolo R, Zweidler-McKay PA and Hughes DPM: Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness. Oncogene. 29:2916–2926. 2010.PubMed/NCBI View Article : Google Scholar
31	Dutta D, Sharma V, Mutsuddi M and Mukherjee A: Regulation of Notch signaling by E3 ubiquitin ligases. FEBS J: Feb 28, 2021 (Epubs ahead of print). doi: 10.1111/febs.15792.
32	Seita J and Weissman IL: Hematopoietic stem cell: Self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med. 2:640–653. 2010.PubMed/NCBI View Article : Google Scholar
33	Sinka L, Biasch K, Khazaal I, Peault B and Tavian M: Angiotensin-converting enzyme (CD143) specifies emerging lympho-hematopoietic progenitors in the human embryo. Blood. 119:3712–3723. 2012.PubMed/NCBI View Article : Google Scholar
34	Suzuki T and Chiba S: Notch signaling in hematopoietic stem cells. Int J Hematol. 82:285–294. 2005.PubMed/NCBI View Article : Google Scholar
35	Saito K, Nobuhisa I, Harada K, Takahashi S, Anani M, Lickert H, Kanai-Azuma M, Kanai Y and Taga T: Maintenance of hematopoietic stem and progenitor cells in fetal intra-aortic hematopoietic clusters by the Sox17-Notch1-Hes1 axis. Exp Cell Res. 365:145–155. 2018.PubMed/NCBI View Article : Google Scholar
36	Zhang P, He Q, Chen D, Liu W, Wang L, Zhang C, Ma D, Li W, Liu B and Liu F: G protein-coupled receptor 183 facilitates endothelial-to-hematopoietic transition via Notch1 inhibition. Cell Res. 25:1093–1107. 2015.PubMed/NCBI View Article : Google Scholar
37	Kumano K, Chiba S, Kunisato A, Sata M, Saito T, Nakagami-Yamaguchi E, Yamaguchi T, Masuda S, Shimizu K, Takahashi T, et al: Notch1 but Not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity. 18:699–711. 2003.PubMed/NCBI View Article : Google Scholar
38	Gama-Norton L, Ferrando E, Ruiz-Herguido C, Liu Z, Guiu J, Islam AB, Lee SU, Yan M, Guidos CJ, López-Bigas N, et al: Notch signal strength controls cell fate in the haemogenic endothelium. Nat Commun. 6(8510)2015.PubMed/NCBI View Article : Google Scholar
39	Jang IH, Lu YF, Zhao L, Wenzel PL, Kume T, Datta SM, Arora N, Guiu J, Lagha M, Kim PG, et al: Notch1 acts via Foxc2 to promote definitive hematopoiesis via effects on hemogenic endothelium. Blood. 125:1418–1426. 2015.PubMed/NCBI View Article : Google Scholar
40	Stier S, Cheng T, Dombkowski D, Carlesso N and Scadden DT: Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood. 99:2369–2378. 2002.PubMed/NCBI View Article : Google Scholar
41	Shao L, Paik NY and Pajcini KV: Hematopoietic jagged1 is required for the transition of hematopoietic stem cells from the fetal liver to the adult bone marrow niche. Blood. 136:10–11. 2020.
42	Ishiko E, Matsumura I, Ezoe S, Gale K, Ishiko J, Satoh Y, Tanaka H, Shibayama H, Mizuki M, Era T, et al: Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. J Biol Chem. 280:4929–4939. 2005.PubMed/NCBI View Article : Google Scholar
43	Henning K, Heering J, Schwanbeck R, Schroeder T, Helmbold H, Schäfer H, Deppert W, Kim E and Just U: Notch1 activation reduces proliferation in the multipotent hematopoietic progenitor cell line FDCP-mix through a p53-dependent pathway but Notch1 effects on myeloid and erythroid differentiation are independent of p53. Cell Death Differ. 15:398–407. 2008.PubMed/NCBI View Article : Google Scholar
44	Yashiro-Ohtani Y, Ohtani T and Pear WS: Notch regulation of early thymocyte development. Semin Immunol. 22:261–269. 2010.PubMed/NCBI View Article : Google Scholar
45	Allman D, Karnell FG, Punt JA, Bakkour S, Xu L, Myung P, Koretzky GA, Pui JC, Aster JC and Pear WS: Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J Exp Med. 194:99–106. 2001.PubMed/NCBI View Article : Google Scholar
46	Gerhardt DM, Pajcini KV, D'Altri T, Tu L, Jain R, Xu L, Chen MJ, Rentschler S, Shestova O, Wertheim GB, et al: The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Genes Dev. 28:576–593. 2014.PubMed/NCBI View Article : Google Scholar
47	Deftos ML and Bevan MJ: Notch signaling in T cell development. Curr Opin Immunol. 12:166–172. 2000.PubMed/NCBI View Article : Google Scholar
48	Tomita K, Hattori M, Nakamura E, Nakanishi S, Minato N and Kageyama R: The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev. 13:1203–1210. 1999.PubMed/NCBI View Article : Google Scholar
49	De Decker M, Lavaert M, Roels J, Tilleman L, Vandekerckhove B, Leclercq G, Van Nieuwerburgh F, Van Vlierberghe P and Taghon T: HES1 and HES4 have non-redundant roles downstream of Notch during early human T-cell development. Haematologica. 106:130–141. 2021.PubMed/NCBI View Article : Google Scholar
50	Haque R and Song J, Haque M, Lei F, Sandhu P, Ni B, Zheng S, Fang D, Yang JM and Song J: c-Myc-Induced survivin is essential for promoting the Notch-dependent T cell differentiation from hematopoietic stem cells. Genes (Basel). 8(97)2017.PubMed/NCBI View Article : Google Scholar
51	Van de Walle I, De Smet G, Gärtner M, De Smedt M, Waegemans E, Vandekerckhove B, Leclercq G, Plum J, Aster JC, Bernstein ID, et al: Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions. Blood. 117:4449–4459. 2011.PubMed/NCBI View Article : Google Scholar
52	Wendorff AA and Ferrando AA: Modeling NOTCH1 driven T-cell acute lymphoblastic leukemia in mice. Bio Protoc. 10(e3620)2020.PubMed/NCBI View Article : Google Scholar
53	Ma W, Gutierrez A, Goff DJ, Geron I, Sadarangani A, Jamieson CA, Court AC, Shih AY, Jiang Q, Wu CC, et al: NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches. PLoS One. 7(e39725)2012.PubMed/NCBI View Article : Google Scholar
54	Bhanushali AA, Babu S, Thangapandi VR, Pillai R, Chheda P and Das BR: Mutations in the HD and PEST domain of Notch-1 receptor in T-cell acute lymphoblastic leukemia: Report of novel mutations from Indian population. Oncol Res. 19:99–104. 2010.PubMed/NCBI View Article : Google Scholar
55	Ding J, Cardoso AA, Yoshimoto M and Kobayashi M: The Earliest T-Precursors in the mouse embryo are susceptible to leukemic transformation. Front Cell Dev Biol. 9(634151)2021.PubMed/NCBI View Article : Google Scholar
56	Di Ianni M, Baldoni S, Del Papa B, Aureli P, Dorillo E, De Falco F, Albi E, Varasano E, Di Tommaso A, Giancola R, et al: NOTCH1 is aberrantly activated in chronic lymphocytic leukemia hematopoietic stem cells. Front Oncol. 8(105)2018.PubMed/NCBI View Article : Google Scholar
57	Spit M, Rieser E and Walczak H: Linear ubiquitination at a glance. J Cell Sci. 132(jcs208512)2019.PubMed/NCBI View Article : Google Scholar
58	Mansour MA: Ubiquitination: Friend and foe in cancer. Int J Biochem Cell Biol. 101:80–93. 2018.PubMed/NCBI View Article : Google Scholar
59	Martins S, Dohmann EMN, Cayrel A, Johnson A, Fischer W, Pojer F, Satiat-Jeunemaître B, Jaillais Y, Chory J, Geldner N and Vert G: Author Correction: Internalization and vacuolar targeting of the brassinosteroid hormone receptor BRI1 are regulated by ubiquitination. Nat Commun. 12(2982)2021.PubMed/NCBI View Article : Google Scholar
60	Barbosa P, Zhaunova L, Debilio S, Steccanella V, Kelly V, Ly T and Ohkura H: SCF-Fbxo42 promotes synaptonemal complex assembly by downregulating PP2A-B56. J Cell Biol. 220(e202009167)2021.PubMed/NCBI View Article : Google Scholar
61	Li ZQ, Chen X and Wang Y: Small molecules targeting ubiquitination to control inflammatory diseases. Drug Discov Today. 26:2414–2422. 2021.PubMed/NCBI View Article : Google Scholar
62	Dybas JM, Herrmann C and Weitzman MD: Ubiquitination at the interface of tumor viruses and DNA damage responses. Curr Opin Virol. 32:40–47. 2018.PubMed/NCBI View Article : Google Scholar
63	Seo J, Kim MW, Bae KH, Lee SC, Song J and Lee EW: The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics. Biochem Pharmacol. 162:21–40. 2019.PubMed/NCBI View Article : Google Scholar
64	Sun T, Liu Z and Yang Q: The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 19(146)2020.PubMed/NCBI View Article : Google Scholar
65	Zuo Y, Feng Q, Jin L, Huang F, Miao Y, Liu J, Xu Y, Chen X, Zhang H, Guo T, et al: Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling. Nat Commun. 11(1146)2020.PubMed/NCBI View Article : Google Scholar
66	Liu Y and Deng J: Ubiquitinationdeubiquitination in the Hippo signaling pathway (Review). Oncol Rep. 41:1455–1475. 2019.PubMed/NCBI View Article : Google Scholar
67	Soysouvanh F, Giuliano S, Habel N, El-Hachem N, Pisibon C, Bertolotto C and Ballotti R: An Update on the role of ubiquitination in melanoma development and therapies. J Clin Med. 10(113)2021.PubMed/NCBI View Article : Google Scholar
68	Jeusset LM and McManus KJ: Developing targeted therapies that exploit aberrant histone ubiquitination in cancer. Cells. 8(165)2019.PubMed/NCBI View Article : Google Scholar
69	Celebi G, Kesim H, Ozer E and Kutlu O: The effect of dysfunctional ubiquitin enzymes in the pathogenesis of most common diseases. Int J Mol Sci. 21(6335)2020.PubMed/NCBI View Article : Google Scholar
70	Liu BQ, Jin J and Li YY: Ubiquitination modification: Critical regulation of IRF family stability and activity. Sci China Life Sci. 64:957–965. 2021.PubMed/NCBI View Article : Google Scholar
71	Chen RH, Chen YH and Huang TY: Ubiquitin-mediated regulation of autophagy. J Biomed Sci. 26(80)2019.PubMed/NCBI View Article : Google Scholar
72	Song YQ, Wu C, Wu KJ, Han QB, Miao XM, Ma DL and Leung CH: Ubiquitination regulators discovered by virtual screening for the treatment of cancer. Front Cell Dev Biol. 9(665646)2021.PubMed/NCBI View Article : Google Scholar
73	Gupta-Rossi N, Le Bail O, Gonen H, Brou C, Logeat F, Six E, Ciechanover A and Israël A: Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem. 276:34371–34378. 2001.PubMed/NCBI View Article : Google Scholar
74	Fostier M, Evans DA, Artavanis-Tsakonas S and Baron M: Genetic characterization of the Drosophila melanogaster Suppressor of deltex gene: A regulator of notch signaling. Genetics. 150:1477–1485. 1998.PubMed/NCBI View Article : Google Scholar
75	Cornell M, Evans DA, Mann R, Fostier M, Flasza M, Monthatong M, Artavanis-Tsakonas S and Baron M: The Drosophila melanogaster Suppressor of deltex gene, a regulator of the Notch receptor signaling pathway, is an E3 class ubiquitin ligase. Genetics. 152:567–576. 1999.PubMed/NCBI View Article : Google Scholar
76	Qiu L, Joazeiro C, Fang N, Wang HY, Elly C, Altman Y, Fang D, Hunter T and Liu YC: Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase. J Biol Chem. 275:35734–35737. 2000.PubMed/NCBI View Article : Google Scholar
77	McGill MA and McGlade CJ: Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem. 278:23196–23203. 2003.PubMed/NCBI View Article : Google Scholar
78	Che F, Chen J, Wan C and Huang X: MicroRNA-27 inhibits autophagy and promotes proliferation of multiple myeloma cells by targeting the NEDD4/Notch1 Axis. Front Oncol. 10(571914)2020.PubMed/NCBI View Article : Google Scholar
79	Baron M: Endocytic routes to Notch activation. Semin Cell Dev Biol. 23:437–442. 2012.PubMed/NCBI View Article : Google Scholar
80	Wilkin M, Tongngok P, Gensch N, Clemence S, Motoki M, Yamada K, Hori K, Taniguchi-Kanai M, Franklin E, Matsuno K and Baron M: Drosophila HOPS and AP-3 complex genes are required for a Deltex-regulated activation of notch in the endosomal trafficking pathway. Dev Cell. 15:762–772. 2008.PubMed/NCBI View Article : Google Scholar
81	Jehn BM, Dittert I, Beyer S, von der Mark K and Bielke W: c-Cbl binding and ubiquitin-dependent lysosomal degradation of membrane-associated Notch1. J Biol Chem. 277:8033–8040. 2002.PubMed/NCBI View Article : Google Scholar
82	Wu G, Lyapina S, Das I, Li J, Gurney M, Pauley A, Chui I, Deshaies RJ and Kitajewski J: SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol. 21:7403–7415. 2001.PubMed/NCBI View Article : Google Scholar
83	Li L, Guturi KKN, Gautreau B, Patel PS, Saad A, Morii M, Mateo F, Palomero L, Barbour H, Gomez A, et al: Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis. J Clin Invest. 128:4525–4542. 2018.PubMed/NCBI View Article : Google Scholar
84	McGill MA, Dho SE, Weinmaster G and McGlade CJ: Numb regulates post-endocytic trafficking and degradation of Notch1. J Biol Chem. 284:26427–26438. 2009.PubMed/NCBI View Article : Google Scholar
85	Chastagner P, Israel A and Brou C: AIP4/Itch regulates Notch receptor degradation in the absence of ligand. PLoS One. 3(e2735)2008.PubMed/NCBI View Article : Google Scholar
86	Sakata T, Sakaguchi H, Tsuda L, Higashitani A, Aigaki T, Matsuno K and Hayashi S: Drosophila Nedd4 regulates endocytosis of notch and suppresses its ligand-independent activation. Curr Biol. 14:2228–2236. 2004.PubMed/NCBI View Article : Google Scholar
87	Henne WM, Buchkovich NJ and Emr SD: The ESCRT pathway. Dev Cell. 21:77–91. 2011.PubMed/NCBI View Article : Google Scholar
88	Moretti J and Brou C: Ubiquitinations in the notch signaling pathway. Int J Mol Sci. 14:6359–6381. 2013.PubMed/NCBI View Article : Google Scholar
89	MacDonald C, Buchkovich NJ, Stringer DK, Emr SD and Piper RC: Cargo ubiquitination is essential for multivesicular body intralumenal vesicle formation. EMBO Rep. 13:331–338. 2012.PubMed/NCBI View Article : Google Scholar
90	Perry JM and Li L: Self-renewal versus transformation: Fbxw7 deletion leads to stem cell activation and leukemogenesis. Genes Dev. 22:1107–1109. 2008.PubMed/NCBI View Article : Google Scholar
91	Iriuchishima H, Takubo K, Matsuoka S, Onoyama I, Nakayama KI, Nojima Y and Suda T: Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression. Blood. 117:2373–2377. 2011.PubMed/NCBI View Article : Google Scholar
92	Thompson BJ, Jankovic V, Gao J, Buonamici S, Vest A, Lee JM, Zavadil J, Nimer SD and Aifantis I: Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J Exp Med. 205:1395–1408. 2008.PubMed/NCBI View Article : Google Scholar
93	Matsuoka S, Oike Y, Onoyama I, Iwama A, Arai F, Takubo K, Mashimo Y, Oguro H, Nitta E, Ito K, et al: Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev. 22:986–991. 2008.PubMed/NCBI View Article : Google Scholar
94	Rathinam C, Thien CB, Langdon WY, Gu H and Flavell RA: The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells. Genes Dev. 22:992–997. 2008.PubMed/NCBI View Article : Google Scholar
95	Rathinam C, Matesic LE and Flavell RA: The E3 ligase Itch is a negative regulator of the homeostasis and function of hematopoietic stem cells. Nat Immunol. 12:399–407. 2011.PubMed/NCBI View Article : Google Scholar
96	Asgarpour K, Shojaei Z, Amiri F, Ai J, Mahjoubin-Tehran M, Ghasemi F, ArefNezhad R, Hamblin MR and Mirzaei H: Exosomal microRNAs derived from mesenchymal stem cells: Cell-to-cell messages. Cell Commun Signal. 18(149)2020.PubMed/NCBI View Article : Google Scholar
97	Moradian Tehrani R, Verdi J, Noureddini M, Salehi R, Salarinia R, Mosalaei M, Simonian M, Alani B, Ghiasi MR, Jaafari MR, et al: Mesenchymal stem cells: A new platform for targeting suicide genes in cancer. J Cell Physiol. 233:3831–3845. 2018.PubMed/NCBI View Article : Google Scholar
98	Mirzaei H, Sahebkar A, Avan A, Jaafari MR, Salehi R, Salehi H, Baharvand H, Rezaei A, Hadjati J, Pawelek JM and Mirzaei HR: Application of mesenchymal stem cells in melanoma: A potential therapeutic strategy for delivery of targeted agents. Curr Med Chem. 23:455–463. 2016.PubMed/NCBI View Article : Google Scholar
99	Mirzaei H, Salehi H, Oskuee RK, Mohammadpour A, Mirzaei HR, Sharifi MR, Salarinia R, Darani HY, Mokhtari M, Masoudifar A, et al: The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model. Cancer Lett. 419:30–39. 2018.PubMed/NCBI View Article : Google Scholar
100	Mianehsaz E, Mirzaei HR, Mahjoubin-Tehran M, Rezaee A, Sahebnasagh R, Pourhanifeh MH, Mirzaei H and Hamblin MR: Mesenchymal stem cell-derived exosomes: A new therapeutic approach to osteoarthritis? Stem Cell Res Ther. 10(340)2019.PubMed/NCBI View Article : Google Scholar
101	Goradel NH, Hour FG, Negahdari B, Malekshahi ZV, Hashemzehi M, Masoudifar A and Mirzaei H: Stem cell therapy: A new therapeutic option for cardiovascular diseases. J Cell Biochem. 119:95–104. 2018.PubMed/NCBI View Article : Google Scholar
102	Mohammadi M, Jaafari MR, Mirzaei HR and Mirzaei H: Mesenchymal stem cell: a new horizon in cancer gene therapy. Cancer Gene Ther. 23:285–286. 2016.PubMed/NCBI View Article : Google Scholar
103	Hatzimichael E and Tuthill M: Hematopoietic stem cell transplantation. Stem Cells Cloning. 3:105–117. 2010.PubMed/NCBI View Article : Google Scholar
104	Walsh K, Margossian S and Duncan CN: Pediatric hematopoietic cell transplantation. J Pediatr Intensive Care. 3:91–101. 2014.PubMed/NCBI View Article : Google Scholar
105	Dessie G, Derbew Molla M, Shibabaw T and Ayelign B: Role of stem-cell transplantation in leukemia treatment. Stem Cells Cloning. 13:67–77. 2020.PubMed/NCBI View Article : Google Scholar
106	Vanderwalde AM, Sun CL, Laddaran L, Francisco L, Armenian S, Berano-Teh J, Wong FL, Popplewell L, Somlo G, Stein AS, et al: Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies. Leukemia. 27:1139–1145. 2013.PubMed/NCBI View Article : Google Scholar
107	Wang Y, Chen H, Chen J, Han M, Hu J, Jiong Hu, Huang H, Lai Y, Liu D, Liu Q, et al: The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China. Cancer Lett. 438:63–75. 2018.PubMed/NCBI View Article : Google Scholar
108	Copelan EA: Medical progress: Hematopoietic stem-cell transplantation. N Engl J Med. 354:1813–1826. 2006.PubMed/NCBI View Article : Google Scholar
109	Doubek M, Folber F, Koristek Z, Brychtova Y, Krejci M, Tomiska M, Navratil M, Mikulasova P and Mayer J: Autologous hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: Still not out of fashion. Ann Hematol. 88:881–887. 2009.PubMed/NCBI View Article : Google Scholar
110	Atsuta Y, Hirakawa A, Nakasone H, Kurosawa S, Oshima K, Sakai R, Ohashi K, Takahashi S, Mori T, Ozawa Y, et al: Late mortality and causes of death among long-term survivors after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 22:1702–1709. 2016.PubMed/NCBI View Article : Google Scholar
111	Wang X, Xia B and Zhang YZ: Progress of Auto-HSCT for treatment of DLBCL-review. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 26:1841–1846. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
112	Alimoghaddam K, Ghavamzadeh A, Jahani M, Jalali A, Jorjani H, Iravani M, Hamidieh AA, Mousavi A, Bahar B, Behfar M, et al: Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran. Arch Iran Med. 14:332–334. 2011.PubMed/NCBI
113	Zhu J: Thoughts on autologous hematopoietic stem cell transplantation and mobilization in Chinese patients with non Hodgkin's lymphoma. Zhonghua Xue Ye Xue Za Zhi. 41:1–4. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
114	Liu JR, Li J and Huang XJ: Problems and progress of autologous hematopoietic stem cell transplantation in multiple myeloma. Zhonghua Xue Ye Xue Za Zhi. 42:82–86. 2021.PubMed/NCBI View Article : Google Scholar : (In Chinese).
115	Zhao Y, Chen X and Feng S: Autologous hematopoietic stem cell transplantation in acute Myelogenous leukemia. Biol Blood Marrow Transplant. 25:e285–e292. 2019.PubMed/NCBI View Article : Google Scholar
116	Passweg JR: Autologous hematopoetic cell transplantation: Preferred consolidation treatment in low-risk AML? Leuk Lymphoma. 60:2341–2342. 2019.PubMed/NCBI View Article : Google Scholar
117	Xuan L and Liu Q: Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. J Hematol Oncol. 14(4)2021.PubMed/NCBI View Article : Google Scholar
118	Yong AS, Brissot E, Rubinstein S, Savani BN and Mohty M: Transplant to treatment-free remission: The evolving view of ‘cure’ in chronic myeloid leukemia. Expert Rev Hematol. 8:785–797. 2015.PubMed/NCBI View Article : Google Scholar
119	Kook MH, Yhim HY, Lee NR, Song EK, Kim HS, Yim CY and Kwak JY: Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation. Korean J Intern Med. 29:123–125. 2014.PubMed/NCBI View Article : Google Scholar
120	Chen X and Feng SZ: Advances in allogeneic hematopoietic stem cell transplantation for severe aplastic anemia. Zhonghua Xue Ye Xue Za Zhi. 33:963–967. 2012.PubMed/NCBI(In Chinese).
121	Peters C: Allogeneic hematopoietic stem cell transplantation to cure transfusion-dependent thalassemia: Timing Matters! Biol Blood Marrow Transplant. 24:1107–1108. 2018.PubMed/NCBI View Article : Google Scholar
122	Del Galy AS, Marouf A, Raffoux E, Robin M, Michonneau D, Sébert M, Sicre de Fontebrune F, Xhaard A, Lengline E, Itzykson R, et al: Correction to: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: Myth and reality. Leukemia. 35(934)2021.PubMed/NCBI View Article : Google Scholar
123	Chen XP, Cao ZR and Hu J: Advances in allogeneic hematopoietic stem cell transplantation for chronic Myelogenous leukemia-review. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 27:1334–1338. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
124	Iioka F, Tanabe H, Honjo G, Misaki T and Ohno H: Resolution of bone, cutaneous, and muscular involvement after haploidentical hematopoietic stem cell transplantation followed by post-transplant cyclophosphamide in adult T-cell leukemia/lymphoma. Clin Case Rep. 8:1553–1559. 2020.PubMed/NCBI View Article : Google Scholar
125	Natarajan V, Bandapalli OR, Rajkumar T, Sagar TG and Karunakaran N: NOTCH1 and FBXW7 mutations favor better outcome in pediatric South Indian T-cell acute lymphoblastic leukemia. J Pediat Hematol Oncol. 37:E23–E30. 2015.PubMed/NCBI View Article : Google Scholar
126	Valliyammai N, Nancy NK, Sagar TG and Rajkumar T: Study of NOTCH1 and FBXW7 mutations and its prognostic significance in South Indian T-cell acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 40:e1–e8. 2018.PubMed/NCBI View Article : Google Scholar
127	Jenkinson S, Koo K, Mansour MR, Goulden N, Vora A, Mitchell C, Wade R, Richards S, Hancock J, Moorman AV, et al: Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial. Leukemia. 27:41–47. 2013.PubMed/NCBI View Article : Google Scholar
128	Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K, Reman O, Witz F, Fagot T, Tavernier E, et al: NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): A Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood. 113:3918–3924. 2009.PubMed/NCBI View Article : Google Scholar
129	Malyukova A, Brown S, Papa R, O'Brien R, Giles J, Trahair TN, Dalla Pozza L, Sutton R, Liu T, Haber M, et al: FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation. Leukemia. 27:1053–1062. 2013.PubMed/NCBI View Article : Google Scholar
130	Saito Y, Aoki Y, Muramatsu H, Makishima H, Maciejewski JP, Imaizumi M, Rikiishi T, Sasahara Y, Kure S, Niihori T, et al: Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia. Leuk Res. 36:1009–1015. 2012.PubMed/NCBI View Article : Google Scholar
131	Huang HL, Weng HY, Wang LQ, Yu CH, Huang QJ, Zhao PP, Wen JZ, Zhou H and Qu LH: Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis. Mol Cancer Ther. 11:1155–1165. 2012.PubMed/NCBI View Article : Google Scholar
132	Zheng R, Li M, Wang S and Liu Y: Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia. Exp Hematol Oncol. 9(31)2020.PubMed/NCBI View Article : Google Scholar
133	Chiba S: Notch signaling in stem cell systems. Stem Cells. 24:2437–2447. 2006.PubMed/NCBI View Article : Google Scholar
134	Tan SH, Bertulfo FC and Sanda T: Leukemia-initiating cells in T-cell acute lymphoblastic leukemia. Front Oncol. 7(218)2017.PubMed/NCBI View Article : Google Scholar
135	Belmonte M, Hoofd C, Weng AP and Giambra V: Targeting leukemia stem cells: Which pathways drive self-renewal activity in T-cell acute lymphoblastic leukemia? Curr Oncol. 23:34–41. 2016.PubMed/NCBI View Article : Google Scholar
136	Gordeeva O: TGFβ family signaling pathways in pluripotent and teratocarcinoma stem Cells' fate decisions: Balancing between self-renewal, differentiation, and cancer. Cells. 8(1500)2019.PubMed/NCBI View Article : Google Scholar
137	Ma L, Wang Y, Hui Y, Du Y, Chen Z, Feng H, Zhang S, Li N, Song J, Fang Y, et al: WNT/NOTCH pathway is essential for the maintenance and expansion of human MGE progenitors. Stem Cell Reports. 12:934–949. 2019.PubMed/NCBI View Article : Google Scholar
138	Rho JY, Bae GY, Chae J, Yu K, Koo DB, Lee KK and Han YM: Transcriptional Properties of the BMP, TGF-β, RTK, Wnt, Hh, Notch, and JAK/STAT signaling molecules in mouse embryonic stem cells. Reproductive Dev Biol. 30:143–156. 2006.
139	Ding D, Lim KS and Eberhart CG: Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres. Acta Neuropathologica Communications. 2(31)2014.PubMed/NCBI View Article : Google Scholar
140	Liu H, Zhu L and Liu YH: Effect of FBXW7 and NOTCH1 mutations on prognosis of patients with adult acute T lymphoblastic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 26:1294–1300. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).